Letybo®
Botulinum Toxin Type Α – 50 units of powder for solution for injection.
The product is intended for use by healthcare professionals only
Adverse Event Reporting
Adverse events must be reported to Croma-Pharma GmbH, email: [email protected]
Report ALL side effects for ALL medications to:
National Medicines Agency
Mesogeion 284
GR-15562 Cholargos, Αthens
Τel: +30 213 2040380/337
Website: http://www.eof.gr
http://www.kitrinikarta.gr